泰格医药

- 300347

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
泰格医药(300347) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入565,047.79371,085.04180,457.14708,547.15540,601.88
营业收入565,047.79371,085.04180,457.14708,547.15540,601.88
二、营业总成本414,218.66272,002.55136,029.14515,654.41387,254.64
营业成本337,092.01222,976.35108,904.89427,700.76323,744.54
营业税金及附加2,143.601,480.48684.952,301.871,382.17
销售费用13,270.368,899.844,491.1114,989.0410,793.79
管理费用52,754.3134,647.1017,092.3663,013.1946,119.80
财务费用-10,575.94-8,809.46-1,596.11-15,812.38-11,891.20
研发费用19,534.3212,808.256,451.9423,461.9317,105.54
资产减值损失----------
公允价值变动收益71,039.4352,975.7617,641.2753,585.7340,258.78
投资收益12,773.549,890.212,578.4710,275.079,246.61
其中:对联营企业和合营企业的投资收益--6,372.44--3,976.25--
汇兑收益----------
三、营业利润231,172.43159,859.7863,089.78258,239.85200,100.72
加:营业外收入687.11454.9784.801,129.911,103.25
减:营业外支出412.59400.2468.37832.02603.86
其中:非流动资产处置损失----------
四、利润总额231,446.94159,914.5163,106.21258,537.74200,600.11
减:所得税费用28,662.2419,105.516,273.6531,365.2023,376.67
五、净利润202,784.70140,809.0056,832.57227,172.54177,223.44
归属于母公司所有者的净利润187,960.44138,833.7056,845.51200,655.20160,465.88
少数股东损益14,824.251,975.30-12.9426,517.3416,757.57
六、每股收益
基本每股收益(元/股)2.17001.61000.66002.32001.8600
稀释每股收益(元/股)2.17001.61000.66002.32001.8600
七、其他综合收益6,697.0710,316.31-4,655.3930,330.0035,058.23
八、综合收益总额209,481.77151,125.3152,177.18257,502.55212,281.67
归属于母公司所有者的综合收益总额192,104.26145,820.7553,759.46222,809.59186,962.01
归属于少数股东的综合收益总额17,377.515,304.56-1,582.2834,692.9625,319.65
下载全部历史数据到excel中 返回页顶